查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
大分子生物分析测试服务市场规模,份额和趋势分析报告：按阶段（临床前,临床）,研究类型（ADME,PD）,用户,类型,治疗领域,细分市场预测2022-2030
市场调查报告书
商品编码
1133328

大分子生物分析测试服务市场规模,份额和趋势分析报告：按阶段（临床前,临床）,研究类型（ADME,PD）,用户,类型,治疗领域,细分市场预测2022-2030

Large Molecule Bioanalytical Testing Services Market Size, Share & Trends Analysis Report By Phase (Preclinical, Clinical), By Test Type (ADME, PD), By End-user, By Type, By Therapeutic Areas, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 137 Pages | 商品交期: 2-10个工作天内

价格

大分子生物分析检测服务市场增长及趋势

根据 Grand View Research, Inc. 的一份新报告，到 2030 年，全球大分子生物分析测试服务市场规模预计将达到 35 亿美元，在预测期内的复合年增长率为 9.1%。在生物标誌物、大分子和其他物质的临床试验中越来越多地使用生物分析测试是该行业的主要驱动力。新兴国家慢性病发病率的上升和对临床试验需求的增加是推动市场增长的因素。例如，根据世界卫生组织的数据，2020 年将有大约 1000 万人死于癌症。癌症估计表明，到 2040 年，将有 3020 万人被诊断出患有癌症。其他方面，例如不断增长的生物製剂、对先进技术的高需求以及对个性化孤儿药和药物的需求，预计将推动这一细分市场的增长。

此外，技术进步、临床试验全球化以及对 CRO 进行临床试验的需求不断增长等因素预计将加速该行业的扩张。然而，大型製药和生物分析公司因 COVID-19 大流行而面临挑战，扰乱了临床研究和治疗。除了 COVID-19 项目的工作量外，包括启动临床试验、临床前研究、生物分析以及与监管机构的互动，现场工作人员的流失也是一个困难来源。用于支持 Covid 试验的生物分析、临床前和临床试验的非 Covid 工作和资源的延迟导致了 4-6 个月的漫长等待时间。我们还必须解决哪些检测与 Covid 相关哪些不是。

大分子生物分析测试服务市场报告亮点

2021年全球行业以临床领域为主。新兴国家慢性病的流行和对临床试验需求的增加预计将推动该领域的增长

2021年ADA板块将主导全球行业，占总收入的最大份额

由于仿製药製造的采用率增加，生物利用度将在 2021 年拥有最大的测试部分份额

由于全球癌症患病率上升，肿瘤领域将在 2021 年占据最大的收入份额

由于医疗保健支出增加，尤其是在印度和中国，预计亚太地区将在预测期内见证最快的复合年增长率

目录

第一章 调查方法和范围

  • 市场细分和范围
    • 步
    • 类型
    • 测试类型
    • 治疗区
    • 最终用户
    • 区域范围
  • 调查方法
  • 信息采购
    • 购买的数据库
    • GVR 内部数据库
    • 次要信息
    • 初步调查
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 型号详情
    • 商品流向分析（模型一）
      • 方法一：商品流动方法
    • 批量定价分析（模型 2）
      • 方法 2：体积分析
  • 二级信息列表
  • 主要信息列表
  • 目的

第二章执行摘要

  • 市场展望

3. 大分子生物分析测试服务市场变量、趋势和范围

  • 市场系列展望
    • 母公司的市场前景
    • 相关/子公司市场展望
  • 绘製渗透率和增长前景
  • 市场动态
    • 市场驱动力分析
      • 越来越关注分析测试
      • 製药和生物製药行业的研发支出不断增加
      • 外包
    • 市场约束分析
      • 外包
  • 大分子生物分析检测服务市场分析工具
    • 行业分析 - 搬运工
    • PESTEL 分析
    • 市场进入策略
  • COVID-19 影响分析
    • COVID-19 恢復分析
  • 重大交易及战略联盟分析

第 4 章大分子生物分析测试服务市场：相位估计和趋势分析

  • 定义和范围
  • 2021 年和 2030 年大分子生物分析测试服务的市场份额
  • 细分仪表板
  • 全球大分子生物分析检测服务市场分阶段展望
  • 2018-2030 年大分子生物分析测试服务市场规模和预测及趋势分析
    • 临床前
      • 有抗体
      • 无抗体（（基于ELISA的测定）
    • 临床

第 5 章大分子生物分析测试服务市场：按类型划分的估计和趋势分析

  • 定义和范围
  • 2021 年和 2030 年大分子生物分析测试服务的市场份额
  • 细分仪表板
  • 按类型分列的全球大分子生物分析测试服务市场展望
  • 2018-2030 年大分子生物分析测试服务市场规模和预测及趋势分析
    • 药代动力学
    • ADA
    • 其他

第 6 章大分子生物分析测试服务市场：测试类型的估计和趋势分析

  • 定义和范围
  • 2021 年和 2030 年大分子生物分析测试服务的市场份额
  • 细分仪表板
  • 全球大分子生物分析测试服务市场展望（按测试类型）
  • 2018-2030 年大分子生物分析测试服务市场规模和预测及趋势分析
    • ADME
    • PD
    • 生物利用度
    • 生物等效性
    • 其他测试

第7章按治疗领域划分的大分子生物分析检测服务市场估计及趋势分析

  • 定义和范围
  • 2021 年和 2030 年大分子生物分析测试服务的市场份额
  • 细分仪表板
  • 全球大分子生物分析检测服务市场展望（按治疗领域）
  • 2018-2030 年大分子生物分析测试服务市场规模和预测及趋势分析
    • 肿瘤学
    • 感染
    • 心脏病学
    • 神经病学
    • 其他

第 8 章按最终用户估计和趋势分析的大分子生物分析测试服务市场

  • 定义和范围
  • 2021 年和 2030 年大分子生物分析测试服务的市场份额
  • 细分仪表板
  • 按最终用户展望的全球大分子生物分析测试服务市场
  • 2018-2030 年大分子生物分析测试服务市场规模和预测及趋势分析
    • 中小企业
      • CRO 和 CMO
      • 赞助机构
      • 其他
    • 大公司
      • CRO 和 CMO
      • 赞助机构
      • 其他

第 9 章大分子生物分析检测服务市场：区域估计和趋势分析

  • 2021 年和 2030 年区域市场份额分析
  • 区域市场仪表板
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 意大利
    • 西班牙
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
  • 多边环境协定
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国

第 10 章 竞争格局

  • 主要市场参与者的最新发展和影响分析
    • 科文斯
      • 公司简介
      • 财务绩效
      • 服务基准
      • 战略举措
    • IQVIA
      • 公司简介
      • 财务绩效
      • 服务基准
      • 战略举措
    • Syneous Health
      • 公司简介
      • 财务绩效
      • 服务基准
      • 战略举措
    • SGS、SA
      • 公司简介
      • 财务绩效
      • 服务基准
      • 战略举措
    • Toxikon
      • 公司简介
      • 财务绩效
      • 服务基准
      • 战略举措
    • Intertek Plc
      • 公司简介
      • 财务绩效
      • 服务基准
      • 战略举措
    • Pace Analytical Services LLC
      • 公司简介
      • 财务绩效
      • 服务基准
      • 战略举措
    • ICON PLC
      • 公司简介
      • 财务绩效
      • 服务基准
      • 战略举措
    • Charles River Laboratories
      • 公司简介
      • 财务绩效
      • 服务基准
      • 战略举措
    • ThermoFisher Scientific
      • 公司简介
      • 财务绩效
      • 服务基准
      • 战略举措
Product Code: GVR-4-68038-979-1

Large Molecule Bioanalytical Testing Services Market Growth & Trends:

The global large molecule bioanalytical testing services market size is expected to reach USD 3.5 billion by 2030, registering a CAGR of 9.1% over the forecast period, according to a new report by Grand View Research, Inc. The increased use of bioanalytical testing in clinical trials of biomarkers, large molecules, and other substances is the main driver of the industry. The rising incidence of chronic diseases and the rising demand for clinical trials in developing nations are the factors driving the market growth. For instance, according to the WHO, around 10 million people died from cancer in 2020. As per the estimates of cancer, 30.2 million people are likely to have cancer by 2040. Other factors that are anticipated to drive the segment growth include a rise in biologics, high demand for advanced technologies, and the need for personalized orphan drugs & medicines.

It is also projected that factors like technological advancement, globalization of clinical trials, and the rising need for CROs to perform clinical trials will accelerate industry expansion. Large pharmaceutical and bioanalytical firms, however, encountered difficulties as a result of the COVID-19 pandemic, which hampered clinical studies and treatments. Along with the workload of the COVID-19 project, which involves starting clinical trials, preclinical testing, doing bioanalysis, and interacting with regulatory bodies, other difficulties include the loss of workers at sites. The non-Covid initiatives were delayed, and there were lengthy 4-6 month wait times as a result of the resources being used to support the bioanalytical, preclinical, and clinical testing for the Covid trials. They must also resolve assays that are related to Covid and those that are not.

Large Molecule Bioanalytical Testing Services Market Report Highlights:

  • The clinical segment dominated the global industry in 2021. The growing prevalence of chronic diseases and increasing demand for clinical trials in developing countries are factors expected to drive segment growth
  • The ADA-type segment dominated the global industry in 2021 and accounted for the largest share of the overall revenue
  • Bioavailability was the largest test segment share in 2021 on account of the increasing adoption in generic drug manufacturing
  • The oncology segment held the largest revenue share in 2021 due to the increasing prevalence of cancer globally
  • Asia Pacific is projected to witness the fastest CAGR during the forecast years due to the rising healthcare expenditure, particularly in India and China

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Phase
    • 1.1.2. Type
    • 1.1.3. Test Type
    • 1.1.4. Therapeutic Areas
    • 1.1.5. End User
    • 1.1.6. Regional scope
    • 1.1.7. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook

Chapter 3. Large Molecule Bioanalytical Testing Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1. Increasing focus on the analytical testing
      • 3.3.1.2. Growing R & D expenditure in the pharmaceutical and biopharmaceutical industries
      • 3.3.1.3. Rising demand for outsourcing of analytical testing
    • 3.3.2. Market restraint analysis
      • 3.3.2.1. Compliance issues while outsourcing
  • 3.4. Large Molecule Bioanalytical Testing Services Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
    • 3.4.2. PESTEL Analysis
    • 3.4.3. Market Entry Strategies
  • 3.5. COVID - 19 Impact Analysis
    • 3.5.1. COVID - 19 recovery analysis
  • 3.6. Major Deals & Strategic Alliances Analysis

Chapter 4. Large Molecule Bioanalytical Testing Services Market: Phase Estimates & Trend Analysis

  • 4.1. Definitions and Scope
  • 4.2. Large Molecule Bioanalytical Testing Services Market Share, 2021 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Large Molecule Bioanalytical Testing Services Market by Phase Outlook
  • 4.5. Large Molecule Bioanalytical Testing Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Preclinical
      • 4.5.1.1. Preclinical market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.2. With Antibody
      • 4.5.1.2.1. With Antibody market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.3. Without Antibody ((ELISA Based Assay)
      • 4.5.1.3.1. Without Antibody (ELISA Based Assay) market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Clinical
      • 4.5.2.1. Clinical market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Large Molecule Bioanalytical Testing Services Market by Type Estimates & Trend Analysis

  • 5.1. Definitions and Scope
  • 5.2. Large Molecule Bioanalytical Testing Services Market Share, 2021 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Large Molecule Bioanalytical Testing Services Market by Type Outlook
  • 5.5. Large Molecule Bioanalytical Testing Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Pharmacokinetics
      • 5.5.1.1. Pharmacokinetics market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. ADA
      • 5.5.2.1. ADA market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3. Others
      • 5.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Large Molecule Bioanalytical Testing Services Market: Test Type Estimates & Trend Analysis

  • 6.1. Definitions and Scope
  • 6.2. Large Molecule Bioanalytical Testing Services Market Share, 2021 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Large Molecule Bioanalytical Testing Services Market by Test Type Outlook
  • 6.5. Large Molecule Bioanalytical Testing Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. ADME
      • 6.5.1.1. ADME market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.2. PD
      • 6.5.2.1. PD market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.3. Bioavailability
      • 6.5.3.1. Bioavailability market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.4. Bioequivalence
      • 6.5.4.1. Bioequivalence market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.5. Other Tests
      • 6.5.5.1. Other Tests market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas Estimates & Trend Analysis

  • 7.1. Definitions and Scope
  • 7.2. Large Molecule Bioanalytical Testing Services Market Share, 2021 & 2030
  • 7.3. Segment Dashboard
  • 7.4. Global Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas Outlook
  • 7.5. Large Molecule Bioanalytical Testing Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.5.1. Oncology
      • 7.5.1.1. Oncology market estimates and forecast 2018 to 2030 (USD Million)
    • 7.5.2. Infectious Diseases
      • 7.5.2.1. Infectious Diseases market estimates and forecast 2018 to 2030 (USD Million)
    • 7.5.3. Cardiology
      • 7.5.3.1. Cardiology market estimates and forecast 2018 to 2030 (USD Million)
    • 7.5.4. Neurology
      • 7.5.4.1. Neurology market estimates and forecast 2018 to 2030 (USD Million)
    • 7.5.5. Others
      • 7.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Large Molecule Bioanalytical Testing Services Market by End - user Estimates & Trend Analysis

  • 8.1. Definitions and Scope
  • 8.2. Large Molecule Bioanalytical Testing Services Market Share, 2021 & 2030
  • 8.3. Segment Dashboard
  • 8.4. Global Large Molecule Bioanalytical Testing Services Market by End User Outlook
  • 8.5. Large Molecule Bioanalytical Testing Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 8.5.1. SMEs
      • 8.5.1.1. SMEs market estimates and forecast 2018 to 2030 (USD Million)
      • 8.5.1.2. CROs & CMOs
      • 8.5.1.2.1. CROs & CMOs market estimates and forecast 2018 to 2030 (USD Million)
      • 8.5.1.3. Sponsor Organizations
      • 8.5.1.3.1. Sponsor Organizations market estimates and forecast 2018 to 2030 (USD Million)
      • 8.5.1.4. Others
      • 8.5.1.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)
    • 8.5.2. Large Firms
      • 8.5.2.1. Large Firms market estimates and forecast 2018 to 2030 (USD Million)
      • 8.5.2.2. CROs & CMOs
      • 8.5.2.2.1. CROs & CMOs market estimates and forecast 2018 to 2030 (USD Million)
      • 8.5.2.3. Sponsor Organizations
      • 8.5.2.3.1. Sponsor Organizations market estimates and forecast 2018 to 2030 (USD Million)
      • 8.5.2.4. Others
      • 8.5.2.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 9. Large Molecule Bioanalytical Testing Services Market: Regional Estimates & Trend Analysis

  • 9.1. Regional market share analysis, 2021 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. North America
    • 9.3.1. North America Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. U.S. Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Canada Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.4. Europe
    • 9.4.1. U.K.
      • 9.4.1.1. U.K. Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.2. Germany
      • 9.4.2.1. Germany Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.3. France
      • 9.4.3.1. France Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.4. Italy
      • 9.4.4.1. Italy Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.5. Spain
      • 9.4.5.1. Spain Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Japan
      • 9.5.1.1. Japan Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.5.2. China
      • 9.5.2.1. China Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.5.3. India
      • 9.5.3.1. India Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.5.4. Thailand
      • 9.5.4.1. Thailand Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.5.5. South Korea
      • 9.5.5.1. South Korea Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Brazil
      • 9.6.1.1. Brazil Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.6.2. Mexico
      • 9.6.2.1. Mexico Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.6.3. Argentina
      • 9.6.3.1. Argentina Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.6.4. Colombia
      • 9.6.4.1. Colombia Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.7. MEA
    • 9.7.1. South Africa
      • 9.7.1.1. South Africa Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.7.2. Saudi Arabia
      • 9.7.2.1. Saudi Arabia Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.7.3. UAE
      • 9.7.3.1. UAE Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. 8.1 Recent Developments & Impact Analysis, By Key Market Participants
    • 10.1.1. Covance
      • 10.1.1.1. Company overview
      • 10.1.1.2. Financial Performance
      • 10.1.1.3. Service benchmarking
      • 10.1.1.4. Strategic initiatives
    • 10.1.2. IQVIA
      • 10.1.2.1. Company overview
      • 10.1.2.2. Financial performance
      • 10.1.2.3. Service benchmarking
      • 10.1.2.4. Strategic initiatives
    • 10.1.3. Syneous Health
      • 10.1.3.1. Company overview
      • 10.1.3.2. Financial performance
      • 10.1.3.3. Service benchmarking
      • 10.1.3.4. Strategic initiatives
    • 10.1.4. SGS, SA
      • 10.1.4.1. Company overview
      • 10.1.4.2. Financial performance
      • 10.1.4.3. Service benchmarking
      • 10.1.4.4. Strategic initiatives
    • 10.1.5. Toxikon
      • 10.1.5.1. Company overview
      • 10.1.5.2. Financial performance
      • 10.1.5.3. Service benchmarking
      • 10.1.5.4. Strategic initiatives
    • 10.1.6. Intertek Plc
      • 10.1.6.1. Company overview
      • 10.1.6.2. Financial performance
      • 10.1.6.3. Service benchmarking
      • 10.1.6.4. Strategic initiatives
    • 10.1.7. Pace Analytical Services LLC
      • 10.1.7.1. Company overview
      • 10.1.7.2. Financial performance
      • 10.1.7.3. Service benchmarking
      • 10.1.7.4. Strategic initiatives
    • 10.1.8. ICON PLC
      • 10.1.8.1. Company overview
      • 10.1.8.2. Financial performance
      • 10.1.8.3. Service benchmarking
      • 10.1.8.4. Strategic initiatives
    • 10.1.9. Charles River Laboratories
      • 10.1.9.1. Company overview
      • 10.1.9.2. Financial performance
      • 10.1.9.3. Service benchmarking
      • 10.1.9.4. Strategic initiatives
    • 10.1.10. ThermoFisher Scientific
      • 10.1.10.1. Company overview
      • 10.1.10.2. Financial performance
      • 10.1.10.3. Service benchmarking
      • 10.1.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Volume price analysis
  • Fig. 9 Large molecule bioanalytical testing services market snapshot (2021)
  • Fig. 10 Large molecule bioanalytical testing services market segmentation
  • Fig. 11 Heat map analysis
  • Fig. 12 Parent market outlook
  • Fig. 13 Ancillary market outlook
  • Fig. 14 Penetration & growth prospect mapping
  • Fig. 15 Market driver relevance analysis (Current & future impact)
  • Fig. 16 Market restraint relevance analysis (Current & future impact)
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 19 Large molecule bioanalytical testing services market phase outlook: Segment dashboard
  • Fig. 20 Large molecule bioanalytical testing services market: Phase movement analysis
  • Fig. 21 Preclinical market, 2018 - 2030 (USD Million)
  • Fig. 22 With antibody market, 2018 - 2030 (USD Million)
  • Fig. 23 Without antibody market, 2018 - 2030 (USD Million)
  • Fig. 24 Clinical market, 2018 - 2030 (USD Million)
  • Fig. 25 Large molecule bioanalytical testing services market type outlook: Segment dashboard
  • Fig. 26 Large molecule bioanalytical testing services market: Type movement analysis
  • Fig. 27 Pharmacokinetics market, 2018 - 2030 (USD Million)
  • Fig. 28 Anti-Drug Antibodies (ADA) market, 2018 - 2030 (USD Million)
  • Fig. 29 Others market, 2018 - 2030 (USD Million)
  • Fig. 30 Large molecule bioanalytical testing services market test type outlook: Segment dashboard
  • Fig. 31 Large molecule bioanalytical testing services market: Test type movement analysis
  • Fig. 32 ADME testing market, 2018 - 2030 (USD Million)
  • Fig. 33 PD market, 2018 - 2030 (USD Million)
  • Fig. 34 Bioavailability market, 2018 - 2030 (USD Million)
  • Fig. 35 Bioequivalence market, 2018 - 2030 (USD Million)
  • Fig. 36 Other tests market, 2018 - 2030 (USD Million)
  • Fig. 37 Large molecule bioanalytical testing services market therapeutic area outlook: Segment dashboard
  • Fig. 38 Large molecule bioanalytical testing services market: Therapeutic area movement analysis
  • Fig. 39 Oncology market, 2018 - 2030 (USD Million)
  • Fig. 40 Infectious diseases market, 2018 - 2030 (USD Million)
  • Fig. 41 Cardiology market, 2018 - 2030 (USD Million)
  • Fig. 42 Neurology market, 2018 - 2030 (USD Million)
  • Fig. 43 Others market, 2018 - 2030 (USD Million)
  • Fig. 44 Large molecule bioanalytical testing services market end-user outlook: Segment dashboard
  • Fig. 45 Large molecule bioanalytical testing services market: End-User movement analysis
  • Fig. 46 SMEs market, 2018 - 2030 (USD Million)
  • Fig. 47 CROs & CMO market, 2018 - 2030 (USD Million)
  • Fig. 48 Sponsor organization market, 2018 - 2030 (USD Million)
  • Fig. 49 Others market, 2018 - 2030 (USD Million)
  • Fig. 50 Large firms market, 2018 - 2030 (USD Million)
  • Fig. 51 CROs & CMOs market, 2018 - 2030 (USD Million)
  • Fig. 52 Sponsor organizations market, 2018 - 2030 (USD Million)
  • Fig. 53 Others market, 2018 - 2030 (USD Million)
  • Fig. 54 Regional market: Key takeaways
  • Fig. 55 Large molecule bioanalytical testing services market: Regional movement analysis
  • Fig. 56 North America. market, 2018 - 2030 (USD Million)
  • Fig. 57 U.S. market, 2018 - 2030 (USD Million)
  • Fig. 58 Canada market, 2018 - 2030 (USD Million)
  • Fig. 59 Europe market, 2018 - 2030 (USD Million)
  • Fig. 60 U.K. market, 2018 - 2030 (USD Million)
  • Fig. 61 Germany market, 2018 - 2030 (USD Million)
  • Fig. 62 France market, 2018 - 2030 (USD Million)
  • Fig. 63 Italy market, 2018 - 2030 (USD Million)
  • Fig. 64 Spain market, 2018 - 2030 (USD Million)
  • Fig. 65 Asia Pacific market, 2018 - 2030 (USD Million)
  • Fig. 66 Japan market, 2018 - 2030 (USD Million)
  • Fig. 67 China market, 2018 - 2030 (USD Million)
  • Fig. 68 India market, 2018 - 2030 (USD Million)
  • Fig. 69 Thailand market, 2018 - 2030 (USD Million)
  • Fig. 70 South Korea market, 2018 - 2030 (USD Million)
  • Fig. 71 Latin America market, 2018 - 2030 (USD Million)
  • Fig. 72 Brazil market, 2018 - 2030 (USD Million)
  • Fig. 73 Mexico market, 2018 - 2030 (USD Million)
  • Fig. 74 Argentina market, 2018 - 2030 (USD Million)
  • Fig. 75 Colombia market, 2018 - 2030 (USD Million)
  • Fig. 76 MEA market, 2018 - 2030 (USD Million)
  • Fig. 77 South Africa market, 2018 - 2030 (USD Million)
  • Fig. 78 Saudi Arabia market, 2018 - 2030 (USD Million)
  • Fig. 79 UAE market, 2018 - 2030 (USD Million)